Merilee Raines
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Merilee Raines
Merilee Raines is recorded as Board Member at TransMedics Group, Inc. (TMDX). TransMedics Group, Inc. reported in an 8-K filed May 26, 2023 that Merilee Raines was appointed director, effective May 25, 2023.
“The shareholders elected Waleed H. Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania, Stephanie Lovell, Merilee Raines and David Weill, M.D. as directors, each to serve on the board of directors of the Company until the 2024 annual meeting of the Company's shareholders to be held in 2024 or until his or her successor is duly elected and qualified in accordance with our restated articles of organization and second amended and restated bylaws, or his or her earlier death, resignation or removal, based on the following votes:”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-05-25–present
-
TransMedics Group, Inc. (TMDX)
SEC 8-K
Current2021-06-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at TransMedics Group, Inc.
Other people whose current roles at this company are on record from its filings.
- Waleed Hassanein CEO, Board Member
- Fernando Araujo CFO
- Gerardo Hernandez CFO
- Anil Ranganath General Counsel
- Matthew Forsyth General Counsel
- David Weill, M.D. Board Member
- Edward M. Basile Board Member
- Edwin M. Kania Board Member
- James R. Tobin Board Member
- Stephanie Lovell Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.